Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review
Open accessThe DOI matches its Crossref record; 304 of the 332 references it cites were found in a registry or an index, and 21 are not checked yet; 105 of the 438 sources its claims cite were checked for support.
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are highly effective in the management of obesity; however, their efficacy and tolerability may be further optimized through complementary nutritional strategies. Such interventions may address key challenges associated with GLP-1RA therapy, including gastrointestinal adverse effects, lean mass loss, and reduced long-term adherence leading to weight regain. Evidence from preclinical and clinical studies indicates that omega-3 polyunsaturated fatty acids may enhance the metabolic benefits of GLP-1RAs and attenuate lean mass loss, primarily via anti-inflammatory pathways and modulation of protein synthesis. Synergistic effects have also been reported with other bioactive compounds—such as flavonoids and anthocyanins, which improve metabolic outcomes; probiotics and prebiotics, which may alleviate gastrointestinal intolerance; and high-quality protein sources, which support body composition preservation. Collectively, these findings suggest that nutritional adjuncts may complement GLP-1RA therapies through convergent physiological mechanisms, including the regulation of inflammation, gut microbiome composition, and cellular metabolism. While current data highlight the promise of integrated pharmaco-nutritional strategies as adjuncts to GLP-1-based obesity therapy, further randomized controlled trials are needed to establish the most effective interventions and protocols.
Verified 2026-11-19 · 21 references not checked yet
Overview
CoChat Summary
TL;DR
This narrative review argues that nutritional adjuncts—fiber/prebiotics, probiotics, protein sources, specific nutrients, and botanical actives—may complement GLP-1 receptor agonist (GLP-1RA) therapy in obesity by improving GI tolerability, preserving lean mass, and amplifying metabolic benefits. However, direct clinical evidence combining these interventions with GLP-1RAs remains scarce, and most proposed synergies are based on indirect, preclinical, or expert-consensus evidence.
Key findings
- GLP-1RAs achieve placebo-adjusted weight loss of 8–21% after one year, but long-term effectiveness is limited by GI adverse events affecting up to 70–85% of patients, nutritional deficiencies, lean mass loss, and weight regain—with up to two-thirds of lost weight returning within one year after discontinuation.
- Nutritional adjuncts with the strongest practice-reasonable support include adequate protein intake, ginger, dietary fiber, and probiotics for preserving lean mass and improving GI tolerability; expert consensus recommends fiber for constipation and probiotics for persistent diarrhea during GLP-1RA treatment.
- Specific evidence cited includes a pilot study of 27 obese patients where a multispecies probiotic plus low-dose liraglutide produced comparable weight loss to higher-dose liraglutide alone, with 59.3% reporting only mild transient GI symptoms and none discontinuing, versus an 80.3% adverse-event incidence in a comparable high-dose liraglutide trial.
- Other reported findings include L. gasseri BNR17 producing a ~22 cm² decrease in visceral adiposity versus placebo; oral glutamine (15 g/day) achieving ≥50-point IBS severity score reduction in 79.6% vs 5.8% with placebo; and omega-3/krill oil trials showing muscle function or lean-mass benefits, though omega-3 evidence is described as mixed.
Methods
- Narrative review with a targeted, non-systematic search in PubMed, Scopus, Google Scholar, and Cochrane up to September 2025, plus manual reference searching.
- Search terms included “GLP-1,” “GLP-1 receptor agonists,” drug names (semaglutide, liraglutide, tirzepatide), intervention descriptors (“nutrition,” “dietary interventions,” “nutraceuticals”), and specific actives (“probiotics,” “fibers,” “botanical extracts”).
- The review prioritized English-language clinical and preclinical studies reporting metabolic and/or GI tolerability outcomes relevant to GLP-1RA therapy, synthesizing preclinical, indirect clinical, and direct clinical findings when available.
Limitations
- The paper states that direct clinical evidence combining nutritional interventions with GLP-1RAs remains limited, that many compounds have not been studied in combination with GLP-1RAs, and that further randomized controlled trials are needed to establish effective interventions and protocols.
- The paper notes that nutritional supplements differ from pharmacological agents in regulatory classification and are not subject to the same pre-market clinical validation, and advises caution in vulnerable populations such as pregnant/lactating women, older adults, critically ill patients, and those with hepatic or renal impairment.
- Evident from the text: the search was non-systematic, with no described protocol, risk-of-bias assessment, or formal evidence grading; many proposed benefits rely on preclinical data, studies in non-GLP-1RA populations, or expert consensus, so several adjunctive roles remain hypothetical.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
24 Valid · 41 Not valid · 244 Not checked · 59 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“A meta-analysis of 16 randomized controlled trials with 1251 adults with chronic constipation showed that fiber, particularly psyllium at doses >10 g/day for ≥4 weeks, significantly improved stool frequency and consistency [132]”
§ Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review > 3.1. Dietary Fibers and Prebiotics
What the sources say
- Disputedcites [132] sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 0 partially supported, 2 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
plainstates a causen = 1,251- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“A meta-analysis of 37 randomized controlled trials confirmed that higher protein intake reduced body weight by ~1.6 kg, with prediabetic subjects benefiting the most [163].”
§ Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review > 3.3. Protein Sources
What the sources say
- Disputedcites [163] sourceExperimental — accuracy not yet measured
The Results (Characteristics of included studies; page unavailable) state that this meta-analysis included 22 studies, not 37. The paper reports glycemic and lipid outcomes, but does not report the claimed ~1.6 kg reduction in body weight or a greatest benefit among prediabetic subjects. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In older adults, >2 g/day was associated with modest gains in muscle mass (0.67 kg) and improvements in walking speed, particularly after interventions > 6 months (1.78 m/s; 95% CI: 1.38-2.17)[190].”
§ Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review > 3.4.4. Omega-3 Polyunsaturated Fatty Acids
What the sources say
- Disputedcites [190] sourceExperimental — accuracy not yet measured
The Results (Eligible studies and baseline characteristics; page unavailable) state that treatment lasted 3–24 weeks, contrary to the claim of an effect particularly after interventions longer than six months. The Methods (Statistical analysis; page unavailable) identify weight, BMI, waist circumference, lipids, and glucose as outcomes; the paper does not report the claimed walking-speed estimate or muscle-mass gain in older adults. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Another randomized controlled trial with 41 overweight/obese adults undergoing an alternate-day fasting regimen showed that KO (4 g/day, SuperbaBoost™, Aker BioMarine ASA, Lysaker, Norway) for 8 weeks attenuated declines in fat-free mass (-0.2 ± 0.9 kg) and handgrip strength (-0.2 ± 0.5 kg) observed in the placebo group [308].”
§ Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review > 3.4.4. Omega-3 Polyunsaturated Fatty Acids
What the sources say
- Disputedcites [308] sourceExperimental — accuracy not yet measured
The Methods (Study population and Intervention; page not provided) describe a 28-day krill-oil study in healthy young adults, with 17 included in the analysis; obesity was an exclusion criterion. Participants were advised to maintain their body weight, not undergo alternate-day fasting. The cited paper therefore describes a different study and does not report the claimed placebo comparison or fat-free-mass and handgrip outcomes. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In metabolic syndrome, pine bark extract (150 mg/day, for 6 months) improved key risk factors: it lowered fasting glucose (~123 to ~105 mg/dL), reduced waist circumference (-7.9 cm in men and -7.3 cm in women), increased adiponectin, and reduced blood pressure and oxidative stress markers [213].”
§ Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review > 3.5.4. French Maritime Pine (Pinus pinaster) Bark Extract
What the sources say
- Disputedcites [213] sourceExperimental — accuracy not yet measured
Table 2 and §3.2 report fasting-glucose results for Guava Leaf Tea, not pine bark extract: 136 to 131 mg/dL after 12 weeks in pre-diabetic and mildly diabetic subjects. The cited paper does not report the claimed 150 mg/day, six-month pine-bark regimen or the change from approximately 123 to 105 mg/dL. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
210 more claims · 42 with their cited sources checked
Create a free account to see all 368 claims and to verify the 333 references still open.
- It may state two separate claims as one. 138
- Probably not a substantial claim. 20
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, distributing protein intake evenly across meals has been found to be particularly effective, as it maximizes muscle protein synthesis throughout the day [72].”
From A Narrative Review on GLP-1 Receptor Agonists for Obesity in Older Women: Maximizing Weight Loss While Preserving Lean Mass (2026) · cites this paper as [72]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Because dietary lipids act synergistically with GLP-1 to inhibit gastric emptying, reducing fat load per meal is a physiologically plausible and commonly recommended strategy to reduce postprandial nausea and fullness during GLP-1 RA titration, although randomized dietary-modification trials specifically in GLP-1-treated cohorts are lacking [66,67].”
From Adherence and Persistence with GLP-1-Based Therapies: International Real-World Evidence and the Role of Nutritional and Lifestyle Support—A Narrative Review (2026) · cites this paper as [67]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review > 3.4.3. Zinc
“Evidence from animal models shows that zinc supplementation reduces weight gain, abdominal fat accumulation, hyperinsulinemia, and leptin levels, while improving insulin resistance in obese mice fed a high-fat, high-fructose diet [183].”
§ Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review > References
“Thoen, R.U.; Barther, N.N.; Schemitt, E.; Bona, S.; Fernandes, S.; Coral, G.; Marroni, N.P.; Tovo, C.; Guedes, R.P.; Porawski, M. Zinc supplementation reduces diet-induced obesity and improves insulin sensitivity in rats.”
Citations
Cites
Items 201–332 of 332
Zinc supplementation reduces diet-induced obesity and improves insulin sensitivity in rats
Thoen, R. U., Barther, N. N., Schemitt, E., Bona, S., Fernandes, S., Coral, G., Marroni, N. P., Tovo, C., Guedes, R. P., & Porawski, M. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2018-0519 · Cited by 43 · cited 1×
“Evidence from animal models shows that zinc supplementation reduces weight gain, abdominal fat accumulation, hyperinsulinemia, and leptin levels, while improving insulin resistance in obese mice fed a high-fat, high-fructose diet [183].”
Olukorode, J., Orimoloye, D. A., Nwachukwu, N. O., ONWUZO, C. N., Oloyede, P. O., Fayemi, T., Odunaike, O. S., Ayobami-Ojo, P. S., Divine, N., Alo, D. J., et al. (2024) · Cureus · doi:10.7759/cureus.72080 · Cited by 42
Pycnogenol® supplementation improves health risk factors in subjects with metabolic syndrome
Belcaro, G., Cornelli, U., Luzzi, R., Cesarone, Dugall, M., Feragalli, B., Errichi, S., Ippolito, E., Grossi, M. G., Hosoi, M., et al. (2013) · Phytotherapy Research · doi:10.1002/ptr.4883 · Cited by 40
Protein- and Calcium-Mediated GLP-1 Secretion: A Narrative Review
Watkins, J. D., Koumanov, F., & Gonzalez, J. T. (2021) · Advances in Nutrition · doi:10.1093/advances/nmab078 · Cited by 40
Kim, J. H., Jung, W. S., Choi, N.-J., Kim, D.-O., Shin, D.-H., & Kim, Y. J. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2008.04.002 · Cited by 39
Pycnogenol® in Metabolic Syndrome and Related Disorders
Gulati, O. P. (2015) · Phytotherapy Research · doi:10.1002/ptr.5341 · Cited by 39 · cited 3×
“Lipid profile also improved, with reductions in LDL and triglycerides, and a rise in HDL [213,214].”
Bergia, R. E., Hudson, J. L., & Campbell, W. W. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nuy017 · Cited by 39
Para a crítica da transição nutricional
Escoda, M. D. S. Q. (2002) · Ciência & Saúde Coletiva · doi:10.1590/s1413-81232002000200002 · Cited by 39
Weichmann, F., & Rohdewald, P. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1389374 · Cited by 38 · cited 1×
“French maritime pine bark extract, derived from Pinus pinaster and rich in procyanidin, is a well-researched botanical with multiple clinically demonstrated benefits, including for metabolic, cardiovascular, and cognitive health [344].”
Ebrahimzadeh, A., Ebrahimzadeh, A., Mirghazanfari, S. M., Hazrati, E., Hadi, S., & Milajerdi, A. (2022) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2022.102802 · Cited by 38
A Nutritional-Toxicological Assessment of Antarctic Krill Oil versus Fish Oil Dietary Supplements
Bengtson Nash, S., Schlabach, M., & Nichols, P. (2014) · Nutrients · doi:10.3390/nu6093382 · Cited by 38
Ren, X., Hua, H., Wu, Y., Zhang, W., Long, X., Bai, Y., & Cheng, N. (2025) · Scientific Reports · doi:10.1038/s41598-025-09807-0 · Cited by 38
Efficacy of Oral Psyllium in Pediatric Irritable Bowel Syndrome
Menon, J., Thapa, B. R., Kumari, R., Kadyada, S. P., Rana, S. V., & Lal, S. B. (2022) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003622 · Cited by 38
Andraka, J. M., Sharma, N., & Marchalant, Y. (2019) · Neuroscience Research · doi:10.1016/j.neures.2019.08.001 · Cited by 37
Obesity-associated Pathways of Anthocyanins
Yıldız, E., Güldaş, M., Ellergezen, P. H., Acar, A. G., & Gürbüz, O. (2020) · Food Science and Technology · doi:10.1590/fst.39119 · Cited by 37
Cesar, T. B., Ramos, F. M. M., & Ribeiro, C. B. (2022) · Journal of Medicinal Food · doi:10.1089/jmf.2021.0181 · Cited by 36
Birdi, T., Krishnan, G. G., Kataria, S., Gholkar, M., & Daswani, P. (2020) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2020.04.001 · Cited by 36 · cited 2×
“Anti-spasmodic and antidiarrheal efficacy; improves stool frequency and consistency in diarrhea; ↓ glucose, insulin, TC, and TG; inhibits α -amylase/ α -glucosidase [114,206–212].”
Tsang, C., Taghizadeh, M., Aghabagheri, E., Asemi, Z., & Jafarnejad, S. (2019) · Clinical Obesity · doi:10.1111/cob.12313 · Cited by 36
Zdzieblik, D., Jendricke, P., Oesser, S., Gollhofer, A., & König, D. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18094837 · Cited by 36
Talab, A. T., Abdollahzad, H., Nachvak, S. M., Pasdar, Y., Eghtesadi, S., Izadi, A., Aghdashi, M. A., Azar, M. R. M. H., Moradi, S., Mehaki, B., et al. (2020) · Clinical Nutrition Research · doi:10.7762/cnr.2020.9.2.97 · Cited by 36
Lam, F.-C., Bukhsh, A., Rehman, H., Waqas, M. K., Shahid, N., Khaliel, A. M., Elhanish, A. A. S., Karoud, M., Telb, A., & Khan, T. M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00317 · Cited by 35
Mathur, R., Dutta, S., Velpandian, T., & Mathur, S. (2015) · Pharmacognosy Research · doi:10.4103/0974-8490.151459 · Cited by 35
Mamun, M. A. A., Faruk, M., Rahman, M. M., Nahar, K., Kabir, F., Alam, M. A., & Subhan, N. (2019) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2019/1897237 · Cited by 34 · cited 1×
“In diet-induced obesity, guava leaf lowered fat deposition, prevented hepatic steatosis, and improved plasma triglycerides and cholesterol [336].”
Lu, C., Chen, X., Yan, X., He, J., & Nie, Z. (2022) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2021.104094 · Cited by 34 · cited 1×
“Two meta-analyses also showed benefits in postoperative nausea [232] and acute chemotherapy-induced vomiting [233].”
Shinjyo, N., Waddell, G., & Green, J. (2020) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2020.100342 · Cited by 34
Ribeiro, C. B., Ramos, F. M., Manthey, J. A., & Cesar, T. B. (2019) · Phytotherapy Research · doi:10.1002/ptr.6386 · Cited by 33
André, H. C. S., Esteves, G. P., Barreto, G., Longhini, F., Dolan, E., & Benatti, F. B. (2022) · Advances in Nutrition · doi:10.1016/j.advnut.2022.11.005 · Cited by 33
Wang, D., Zhou, L., Zhou, H., Hu, H., & Hou, G. (2021) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.10904 · Cited by 33
Zinc Deficiency and Therapeutic Value of Zinc Supplementation in Pediatric Gastrointestinal Diseases
Chao, H.-C. (2023) · Nutrients · doi:10.3390/nu15194093 · Cited by 33
Despain, D., & Hoffman, B. L. (2024) · Obesity Pillars · doi:10.1016/j.obpill.2024.100143 · Cited by 33
Li, Y., Wu, Y., Wu, L., Qin, L., & Liu, T. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03695-y · Cited by 32
Powell, W., Song, X., Mohamed, Y., Walsh, D., Parks, E. J., McMahon, T. M., Khan, M., & Waitman, L. R. (2023) · Obesity · doi:10.1002/oby.23859 · Cited by 32
Gentinetta, S., Sottotetti, F., Manuelli, M., & Cena, H. (2024) · Diabetes, Metabolic Syndrome and Obesity · doi:10.2147/dmso.s494919 · Cited by 32 · cited 7×
“Furthermore, long-term therapy is associated with nutritional deficiencies, lean mass loss, and frequent GI adverse events, including nausea, vomiting, diarrhea, and constipation, which may affect up to 70–85% of patients and lead to treatment discontinuation [22,38,41,60,61].”
InfluentialVan den Abbeele, P., Duysburgh, C., Cleenwerck, I., Albers, R., Marzorati, M., & Mercenier, A. (2021) · Microorganisms · doi:10.3390/microorganisms9102142 · Cited by 31 · cited 1×
“This soluble fiber from carrot pomace, rich in complex pectin domains (RG-I), selectively modulates gut microbiota and enhances SCFA production, notably acetate and propionate [72,73,133].”
Revealing the Potency of Growth Factors in Bovine Colostrum
Yalçıntaş, Y. M., Duman, H., López, J. M. M., Portocarrero, A. C. M., Lombardo, M., Khallouki, F., Koch, W., Bordiga, M., El-Seedi, H., Raposo, A., et al. (2024) · Nutrients · doi:10.3390/nu16142359 · Cited by 31 · cited 1×
“…contains high levels of immunoglobulins (IgG, IgA), lactoferrin, insulin-like growth factors (IGF-1/2), transforming growth factor-β (TGF-β ), and other bioactive peptides that enhance mucosal healing, reduce inflammation, neutralize pathogens, and support glucose and protein metabolism [274–276].”
Qureshi, A. S., Ghaffor, J., Usman, M., Ehsan, N., Umar, Z., & Sarfraz, A. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00457-4 · Cited by 31
Deaths Attributable to High Body Mass in Brazil
Rabacow, F. M., Azeredo, C. M., & Rezende, L. F. M. (2019) · Preventing Chronic Disease · doi:10.5888/pcd16.190143 · Cited by 31
Kabisch, S., Weickert, M. O., & Pfeiffer, A. F. H. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2141190 · Cited by 31
Centner, C., Jerger, S., Mallard, A. R., Herrmann, A., Varfolomeeva, E., Gollhofer, S. M., Oesser, S., Sticht, C., Gretz, N., Aagaard, P., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.838004 · Cited by 30
Sousa, T. F. D., Nahas, M. V., Silva, D. A. S., Del Duca, G. F., & Peres, M. A. (2011) · Revista Brasileira de Epidemiologia · doi:10.1590/s1415-790x2011000200011 · Cited by 29
Cheah, K. J., & Cheah, L. J. (2023) · Nutrition Journal · doi:10.1186/s12937-023-00880-7 · Cited by 29 · cited 2×
“Whey protein (WP), a high-quality milk-derived protein, contains all essential amino acids required for muscle growth and repair, supporting its applications in sports nutrition, weight management, and sarcopenia [156,266].”
InfluentialDavison, G., Jones, A. W., Marchbank, T., & Playford, R. J. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02004-6 · Cited by 29
Chiang, S.-W., Liu, H.-W., Loh, E.-W., Tam, K.-W., Wang, J.-Y., Huang, W.-L., & Kuan, Y.-C. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.04.002 · Cited by 28 · cited 1×
“Protein also enhances GLP-1, GIP, and insulin secretion, increasing satiety, and delays gastric emptying [32,157,158,161], thereby contributing to weight loss and improved glucose control.”
Mozaffarian, D., Agarwal, M., Aggarwal, M., Alexander, L., Apovian, C. M., Bindlish, S., Bonnet, J., Butsch, W. S., Christensen, S., Gianos, E., et al. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100181 · Cited by 28
Smedegaard, S., Kampmann, U., Ovesen, P. G., Støvring, H., & Rittig, N. (2023) · The American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.05.012 · Cited by 28
Hasle, G., Raastad, R., Bjune, G., Jenum, P. A., & Heier, L. (2017) · Journal of Travel Medicine · doi:10.1093/jtm/tax057 · Cited by 28
Paudel, K. R., Orent, J., & Penela, O. G. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1619655 · Cited by 28
Johnson, B. V. B., Milstead, M., Kreider, R., & Jones, R. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100209 · Cited by 27
Khan, H. B. H., Shanmugavalli, R., Rajendran, D., Bai, M. R., & Sorimuthu, S. (2013) · Journal of Dietary Supplements · doi:10.3109/19390211.2013.830677 · Cited by 27
Safety of a novel galacto-oligosaccharide: Genotoxicity and repeated oral dose studies
Kobayashi, T., Yasutake, N., Uchida, K., Ohyama, W., Kaneko, K., & Onoue, M. (2009) · Human & Experimental Toxicology · doi:10.1177/0960327109346789 · Cited by 27
Balshaw, T. G., Funnell, M. P., McDermott, E., Maden‐Wilkinson, T. M., Abela, S., Quteishat, B., Edsey, M., James, L. J., & Folland, J. P. (2023) · Acta Physiologica · doi:10.1111/apha.13903 · Cited by 26
Bovine colostrum and product intervention associated with relief of childhood infectious diarrhea
Li, J., Xu, Y.-W., Jiang, J.-J., & Song, Q.-K. (2019) · Scientific Reports · doi:10.1038/s41598-019-39644-x · Cited by 25
Dietary Fiber: Nutritional Lessons for Macronutrient Substitutes
Behall, K. M. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb51805.x · Cited by 25
Briskey, D. R., Malfa, G. A., & Rao, A. (2022) · Nutrients · doi:10.3390/nu14030427 · Cited by 25
Sheikhhossein, F., Borazjani, M., Jafari, A., Askari, M., Vataniyan, E., Gholami, F., & Amini, M. R. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.07.010 · Cited by 24 · cited 1×
“Mechanisms include anti-inflammatory and antioxidant effects, inhibition of digestive enzymes ( α -glucosidase and α -amylase), enhancement of glucose transport via GLUT-4, improved insulin sensitivity through adiponectin and PPAR-γ pathways, protection of β -cells, and AMPK activation [353,354].”
(ANS), E. P. O. F. A. A. N. S. A. T. F. (2010) · EFSA Journal · doi:10.2903/j.efsa.2010.1883 · Cited by 24
Efthymakis, K., & Neri, M. (2022) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2022.101954 · Cited by 23 · cited 1×
“Zinc strengthens tight junctions through regulation of occludin proteolysis and claudin-3 transcription [290], increases mucus production, and reduces gastric acid secretion [184,291,292], while also promoting wound healing [293].”
Oh, J., Ahn, S., Zhou, X., Lim, Y. J., Hong, S., & Kim, H. (2023) · Nutrients · doi:10.3390/nu15245110 · Cited by 23
Segal, L. M., Penman, M., & Piriou, Y. (2018) · Toxicology Reports · doi:10.1016/j.toxrep.2018.03.013 · Cited by 23
A comparative study to assess the use of chromium in type 2 diabetes mellitus
Alkhalidi, F., & Department of Community Medicine, C. O. M. (2023) · Journal of Medicine and Life · doi:10.25122/jml-2023-0081 · Cited by 22 · cited 2×
“Improvements in insulin sensitivity and glycemic control [174–176] could potentiate GLP-1RA efficacy, although chromium’s role may be sup-Obesities portive rather than primary.”
Modification of tight junction structure and permeability by nutritional means
Mullin, J. M., Skrovanek, S. M., & Valenzano, M. C. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04028.x · Cited by 21
Psyllium Husk Should Be Taken at Higher Dose with Sufficient Water to Maximize Its Efficacy
Garg, P. (2017) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2017.03.001 · Cited by 21 · cited 1×
“The highest efficacy occurs with adequate dosage (20–25 g/day) and fluid intake (~500 mL with 25 g fiber) [64,65].”
Hu, D., Liu, W., Yu, W., Huang, L., Ji, C., Liu, X., & Lu, Z. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2197076 · Cited by 21
Effects of Omega-3 fatty acids supplementation and resistance training on skeletal muscle
Uchida, Y., Tsuji, K., & Ochi, E. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.03.019 · Cited by 21
Bahrani, A. H. M., Zaheri, H., Soltani, N., Kharazmi, F., Keshavarz, M., & Kamalinajad, M. (2012) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2012.21023 · Cited by 20 · cited 1×
“…benefits extend to vascular function: in obese mice, it improved endothelial function alongside lowered glucose [211], and in diabetic rats, it normalized lipid profiles and plasma glucose while restoring vascular reactivity, further supporting its potential to reduce cardiovascular risk [337].”
Jang, A.-R., Jung, D.-H., Lee, T.-S., Kim, J.-K., Lee, Y.-B., Lee, J.-Y., Kim, S.-Y., Yoo, Y.-C., Ahn, J.-H., Hong, E.-H., et al. (2024) · Nutrition · doi:10.1016/j.nut.2024.112565 · Cited by 20 · cited 1×
“Although specific data on L. gasseri BNR17 and GLP-1 are limited, related Lactobacillus strains increased intestinal GLP-1 expression in animal studies [145,147,222,256,258].”
Abbasi, F., Haghighat Lari, M. M., Khosravi, G. R., Mansouri, E., Payandeh, N., & Milajerdi, A. (2024) · Amino Acids · doi:10.1007/s00726-024-03420-7 · Cited by 19 · cited 2×
“…of 10 randomized controlled trials ( n = 352) found that while glutamine overall did not significantly alter gut permeability, subgroup analyses revealed a reduction at doses >30 g/day for less than 2 weeks, supporting context-specific efficacy to strengthen the epithelial barrier [179].”
Ali, A. A., Naqvi, S. K., Hasnain, Z., Zubairi, M. B. A., Sharif, A., Salam, R. A., Soofi, S., Ariff, S., Nisar, Y. B., & Das, J. K. (2024) · Journal of Global Health · doi:10.7189/jogh.14.04212 · Cited by 19
Rajput, R., & Kumar, K. (2021) · Materials Today: Proceedings · doi:10.1016/j.matpr.2021.04.617 · Cited by 19
Evaluation of acute and sub-chronic toxicity of bitter melon seed extract in Wistar rats
Chung, W.-Y., Jadhav, S., Hsu, P.-K., & Kuan, C.-M. (2022) · Toxicology Reports · doi:10.1016/j.toxrep.2022.04.024 · Cited by 19
Chen, K., Man, S., Wang, H., Gao, C., Li, X., Liu, L., Wang, H., Wang, Y., & Lu, F. (2022) · Food & Function · doi:10.1039/d2fo01884e · Cited by 19
Giglio, B. M., Lobo, P. C. B., & Pimentel, G. D. (2023) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.09.014 · Cited by 18 · cited 1×
“These mechanisms may synergize with GLP-1RA therapy by optimizing outcomes and mitigating lean mass loss, which is critical for preventing chronic diseases and enhancing quality of life [260].”
Kaewdech, A., Sripongpun, P., Wetwittayakhlang, P., & Churuangsuk, C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1008464 · Cited by 18 · cited 3×
“…and partly hydrolyzed guar gum) exert antidiarrheal effects by maintaining luminal water, forming soft and bulky stools, and serving as fermentable substrates that generate SCFAs, which contribute to motility, mucosal integrity, microbiota modulation, and GLP-1 secretion [60,131,247–249].”
Dietary Fiber as Prebiotics: A Mitigation Strategy for Metabolic Diseases
Gao, X., Hu, S., Liu, Y., Alwis, S. A. S. S. D., Yu, Y., Li, Z., Wang, Z., & Liu, J. (2025) · Foods · doi:10.3390/foods14152670 · Cited by 18
Jonker, D., Fowler, P., Albers, R., Tzoumaki, M. V., Hof, K. H. V. H., & Aparicio-Vergara, M. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111243 · Cited by 18
Reilly, D. M., Kynaston, L., Naseem, S., Proudman, E., & Laceby, D. (2024) · Dermatology Research and Practice · doi:10.1155/2024/8752787 · Cited by 18
Obesity treatment in adolescents and adults in the era of personalized medicine
Sundbom, M., Järvholm, K., Sjögren, L., Nowicka, P., & Lagerros, Y. T. (2024) · Journal of Internal Medicine · doi:10.1111/joim.13816 · Cited by 17
Ginger for treating nausea and vomiting: an overview of systematic reviews and meta-analyses
Li, Z., Wu, J., Song, J., & Wen, Y. (2024) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2023.2284647 · Cited by 17
Ramos, F. M. M., Ribeiro, C. B., Cesar, T. B., Milenkovic, D., Cabral, L., Noronha, M. F., & Sivieri, K. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3654 · Cited by 17 · cited 2×
“In prediabetics, 200 mg/day for 12 weeks favorably shifted gut microbiota (increasing Ru-Obesities minococcaceae and decreasing dysbiosis-associated Lachnospiraceae), correlating with better glycemic outcomes [221].”
Cicero-Sarmiento, C. G., Ortíz‐Andrade, R., Araujo‐León, J. A., Campos, M. R. S., Vazquez-Garcia, P., Rubio-Zapata, H., Hernández-Baltazar, E., Yáñez‐Pérez, V., Sánchez‐Recillas, A., Sánchez‐Salgado, J. C., et al. (2022) · Scientia Pharmaceutica · doi:10.3390/scipharm90020028 · Cited by 17
Ogden, H., Child, R., Fallowfield, J., Delves, S., Westwood, C. S., Millyard, A., & Layden, J. (2020) · Nutrients · doi:10.3390/nu12102953 · Cited by 17
Geidam, Y. A., Ambali, A. G., Onyeyili, P. A., Tijjani, M. B., Gambo, H. I., & Gulani, I. A. (2015) · Veterinary World · doi:10.14202/vetworld.2015.358-362 · Cited by 15
Análise da Política de Alimentação e Nutrição no Brasil: 20 anos de história
Filho, M. B. (2021) · Cadernos de Saúde Pública · doi:10.1590/0102-311x00038721 · Cited by 15
Kou, G., Hu, Y., Jiang, Z., Li, Z., Li, P., Song, H., Chen, Q., Zhou, Z., & Lyu, Q. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103860 · Cited by 14
Playford, R. J. (2021) · Nutrients · doi:10.3390/nu14010092 · Cited by 14
Phimarn, W., Sungthong, B., Saramunee, K., & Caichompoo, W. (2018) · Pharmacognosy Magazine · doi:10.4103/pm.pm_215_17 · Cited by 14
Muthukuda, D. T., de Silva, C. K., Ajanthan, S., Wijesinghe, N., Dahanayaka, A., & Pathmeswaran, A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0317904 · Cited by 14
Toxicological evaluations of colostrum ultrafiltrate
Thiel, A., Glávits, R., Murbach, T. S., Endres, J. R., Reddeman, R. A., Hirka, G., Vértesi, A., Béres, E., & Szakonyiné, I. P. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.02.017 · Cited by 14
Kokubo, E., Morita, S., Nagashima, H., Oshio, K., Iwamoto, H., & Miyaji, K. (2022) · Nutrients · doi:10.3390/nu14122386 · Cited by 13 · cited 1×
“In more recent trials with T2DM and prediabetic patients, fiber consumption was associated with reduced HbA1c and fasting glucose, increased microbiota diversity, and elevated insulin and C-peptide levels [127,128].”
Jian, C., Sorensen, N., Lutter, R., Albers, R., de Vos, W., Salonen, A., & Mercenier, A. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116561 · Cited by 13
Al-Rawhani, A. H., Adznam, S. N., Abu Zaid, Z., Md. Yusop, N. B., M. Sallehuddin, H., & Alshawsh, M. A. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.08.033 · Cited by 13
Parker, C., Hunter, K. A., Johnson, M. A., Sharpe, G. R., Gibson, G. R., Walton, G. E., Poveda, C., Cousins, B., & Williams, N. C. (2023) · European Journal of Sport Science · doi:10.1080/17461391.2023.2216657 · Cited by 13
Mes, J. J., van den Belt, M., van der Haar, S., Oosterink, E., Luijendijk, T., Manusama, K., van Dam, L., de Bie, T., Witkamp, R., & Esser, D. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119756 · Cited by 13 · cited 1×
“These improvements in glucose homeostasis were confirmed by a later meta-analysis of 10 studies (1045 T2DM patients) [198] and several more recent trials in prediabetic and diabetic individuals [195–197].”
Rafieipour, N., Gharbi, N., Rahimi, H., Kohansal, A., Sadeghi‐Dehsahraei, H., Fadaei, M., Tahmasebi, M., Momeni, A., Ostovar, N., Ahmadi, M., et al. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad149 · Cited by 13
Liu, C., Jullian, V., & Chassagne, F. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1459066 · Cited by 12 · cited 1×
“Besides metabolic benefits, guava leaf extract is a traditional anti-diarrheal that has gained scientific support [115] and may be potentially useful for GLP-1RA-related diarrhea.”
Effects of ginger constituent 6-shogaol on gastroesophageal vagal afferent C-fibers
Huang, Y., Patil, M. J., Yu, M., Liptak, P., Undem, B. J., Dong, X., Wang, G., & Yu, S. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13585 · Cited by 12
Ji, X., Ye, X., Ji, S., Zhang, S., Wang, Y., Zhou, Z., Xiang, D., & Luo, B. (2025) · Nutrients · doi:10.3390/nu17162579 · Cited by 12
Safety of Whey basic protein isolates as a novel food pursuant to Regulation (EU) 2015/2283
EFSA Panel on Dietetic Products, N. A. A. (. N. P., Turck, D., Bresson, J., Burlingame, B., Dean, T., Fairweather‐Tait, S. J., Heinonen, M., Hirsch‐Ernst, K. I., Mangelsdorf, I., McArdle, H. J., et al. (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5360 · Cited by 12
Yaghmoor, S. S., & Khoja, S. M. (2010) · Journal of Biological Sciences · doi:10.3923/jbs.2010.761.766 · Cited by 11
Piri Damaghi, M., Mirzababaei, A., Moradi, S., Daneshzad, E., Tavakoli, A., Clark, C. C. T., & Mirzaei, K. (2022) · British Journal of Nutrition · doi:10.1017/s0007114521001550 · Cited by 11 · cited 1×
“WP increases plasma essential amino acids; stimulates muscle protein synthesis; and, when combined with exercise, enhances protein kinase B/mammalian target of rapamycin (AKT/mTOR) signaling, promoting an increase in lean mass [149,150].”
López-Yoldi, M., Riezu-Boj, J. I., Abete, I., Ibero-Baraibar, I., Aranaz, P., González-Salazar, I., Izco, J. M., Recalde, J. I., González-Navarro, C. J., Milagro, F. I., et al. (2024) · Nutrients · doi:10.3390/nu16203550 · Cited by 11 · cited 1×
“In a 3-month trial, bovine collagen bar (20 g/day) before meals in overweight/obese individuals reduced body weight ( − 3 kg), BMI, waist circumference, systolic blood pressure, and fatty liver index, alongside improvements in fat-free mass and satiety [162].”
Mercenier, A., Vu, L. D., Poppe, J., Albers, R., McKay, S., & den Abbeele, P. V. (2024) · Metabolites · doi:10.3390/metabo14120722 · Cited by 11
Lactobacillus gasseri as a Functional Food and Its Role in Obesity
Mahboubi, M. (2019) · International Journal of Medical Reviews · doi:10.29252/ijmr-060206 · Cited by 10 · cited 2×
“For instance, Lactobacillus gasseri BNR17 ( L. gasseri BNR17) has shown anti-obesity effects, which might amplify and sustain GLP-1RAs-induced weight loss, particularly by reducing abdominal adiposity [257].”
Garg, P., Garg, P. K., & Bhattacharya, K. (2024) · Gastroenterology · doi:10.1053/j.gastro.2023.11.019 · Cited by 10 · cited 3×
“Outside the enteral nutrition setting, psyllium has demonstrated mechanisms relevant to GLP-1RA-related GI adverse events, including constipation and irritable bowel syndrome (IBS) [64,250,251].”
EFSA Panel on Nutrition, N. F. A. F. A. (., Turck, D., Bohn, T., Castenmiller, J. J. M., Henauw, S. D., Hirsch‐Ernst, K. I., Maciuk, A., Mangelsdorf, I., McArdle, H. J., Naska, A., et al. (2022) · EFSA Journal · doi:10.2903/j.efsa.2022.7203 · Cited by 10
Park, J., Kim, M., Shin, H., Ahn, H., & Park, Y. K. (2023) · Clinical Nutrition Research · doi:10.7762/cnr.2023.12.4.245 · Cited by 9 · cited 1×
“Similar effects were observed in older adults ( ≥ 50 years) with habitual physical activity (reduced body fat) [166], healthy men (increased muscle volume and fat-free mass) [268,269], and middle-aged untrained men, where collagen peptides and WP elicited comparable improvements [270].”
Ibeh, L. N., Ijioma, S. N., Emmanuel, O., Timothy, C. O., & Ugbogu, E. A. (2021) · Biomarkers · doi:10.1080/1354750x.2021.1992651 · Cited by 9
Brown, A., Mellor, D., Makaronidis, J., Shuttlewood, E., Miras, A. D., & Pournaras, D. J. (2024) · Nutrition Bulletin · doi:10.1111/nbu.12700 · Cited by 9
Lee, S., Baek, M.-O., Khaliq, S. A., Parveen, A., Kim, S. Y., Kim, J.-H., Kim, I.-C., & Yoon, M.-S. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105483 · Cited by 9
Cong, H., Zhong, W., Wang, Y., Ikuyama, S., Fan, B., & Gu, J. (2018) · Journal of Diabetes Research · doi:10.1155/2018/9713259 · Cited by 9 · cited 2×
“↓ fasting glucose, waist, BP, oxidative stress markers, LDL, and TG; ↑ HDL and adiponectin; improves endothelial function; inhibits α -amylase/ α -glucosidase [213–220].”
Sturgeon, J. P., Mutasa, K., Bwakura-Dangarembizi, M., Amadi, B., Ngosa, D., Dzikiti, A., Chandwe, K., Besa, E., Mutasa, B., Murch, S. H., et al. (2025) · eBioMedicine · doi:10.1016/j.ebiom.2024.105478 · Cited by 8 · cited 1×
“Supplementation prevented the increase in intestinal permeability caused by non-steroidal anti-inflammatory drugs (NSAIDs) [168]; reduced the incidence, duration, and severity of pediatric infectious diarrhea [277–281]; and ameliorated gut dysfunction in malnutrition [282].”
Purnasari, P. W., Nasihun, T., & Zulaikhah, S. T. (2021) · Folia Medica · doi:10.3897/folmed.63.e53768 · Cited by 8 · cited 1×
“Preclinical data also suggest that zinc may enhance GLP-1 secretion, potentially mediated by improved intestinal villi proliferation [294].”
Acute and chronic toxicity evaluation of methanol leaf extract of Psidium guajava (Myrtaceae)
Igwe, J. O., Abone, H. O., Ezea, M. C., Ejikeugwu, C. P., & Esimone, C. O. (2021) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2021.16.3.0270 · Cited by 8
(EFSA), E. F. S. A. (2009) · EFSA Journal · doi:10.2903/j.efsa.2009.938 · Cited by 7
EFSA Panel on Nutrition, N. F. A. F. A. (., Bohn, T., Cámara, M., Castenmiller, J. J. M., Henauw, S. D., Hirsch‐Ernst, K. I., Jos, A. M., Maciuk, A., Mangelsdorf, I., McNulty, B. A., et al. (2025) · EFSA Journal · doi:10.2903/j.efsa.2025.9160 · Cited by 6
Amini, M. R., Rasaei, N., Jalalzadeh, M., Pourreza, S., & Hekmatdoost, A. (2024) · Phytotherapy Research · doi:10.1002/ptr.8357 · Cited by 5
Evaluation of Drug-diet interaction between Psidium guajava (Guava) fruit and Metoclopramide
Amadi, C. N., & Aghalibe, P. O. (2019) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v9i2.2441 · Cited by 5
Kerezoudi, E. N., McKay, S., Kurt, S., Kreek, M. D., Medts, J. D., Verstrepen, L., Ghyselinck, J., Meulebroek, L. V., Calame, W., Mercenier, A., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13092156 · Cited by 5
Reynolds, K. M., Hansell, E. J., Thorley, J., Funnell, M. P., Thackray, A. E., Stensel, D. J., Bailey, S. J., James, L. J., Prawitt, J., Virgilio, N., et al. (2025) · British Journal of Nutrition · doi:10.1017/s0007114525103851 · Cited by 4 · cited 2×
“Protein also enhances GLP-1, GIP, and insulin secretion, increasing satiety, and delays gastric emptying [32,157,158,161], thereby contributing to weight loss and improved glucose control.”
Henriques, H. K. F., Kattah, F. M., Piccolo, M. S., dos Santos, E. A., de Araújo Ventura, L. H., Cerqueira, F. R., Vieira, C. M. A. F., & Leite, J. I. A. (2025) · Obesities · doi:10.3390/obesities5020042 · Cited by 4 · cited 1×
“In a clinical study with women, supplementation with 30 g of WP per day for 4 weeks resulted in greater reductions in body weight and fat mass, together with an increase in fat-free mass [267].”
Playford, R. J. (2024) · Nutrients · doi:10.3390/nu16213684 · Cited by 4
Hajihashemi, P., Haghighatdoost, F., Kassaian, N., Hoveida, L., Tamizifar, B., Nili, H., Rahim Khorasani, M., & Adibi, P. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08219-2 · Cited by 4 · cited 1×
“In adults, colostrum reduced gut permeability in critical illness [283] and, in athletes, a meta-analysis of 10 randomized trials demonstrated improvements in intestinal permeability via urinary lactulose/rhamnose and lactulose/mannitol ratios, supporting its role in gut barrier protection [169].”
Kobayashi, T., Takano, M., Kaneko, K., & Onoue, M. (2013) · Human & Experimental Toxicology · doi:10.1177/0960327113510328 · Cited by 4
Alblaji, M., Gray, S. R., Almesbehi, T., Morrison, D. J., & Malkova, D. (2025) · Obesity · doi:10.1002/oby.24354 · Cited by 3
Portillo-Rentería, G., Toro-Equihua, M. D., Sánchez‐Meza, K., Ríos‐Silva, M., Alcaraz-Siqueiros, J., Uribarren, J., & Cárdenas, Y. (2024) · Journal of Medicinal Food · doi:10.1089/jmf.2024.0227 · Cited by 3
Chawla, I., Dhanawat, M., Sharma, M., & Gupta, S. (2025) · Current Diabetes Reviews · doi:10.2174/0115733998275676240202065952 · Cited by 2 · cited 2×
“…contains high levels of immunoglobulins (IgG, IgA), lactoferrin, insulin-like growth factors (IGF-1/2), transforming growth factor-β (TGF-β ), and other bioactive peptides that enhance mucosal healing, reduce inflammation, neutralize pathogens, and support glucose and protein metabolism [274–276].”
Nutritional and Functional Importance of Whey Protein in Human Health and Food Applications
(2024) · Applied Agriculture Sciences · doi:10.25163/agriculture.2198922 · Cited by 2
EFSA Panel on Nutrition, N. F. A. F. A. (., Turck, D., Bohn, T., Cámara, M., Castenmiller, J. J. M., Henauw, S. D., Jos, A. M., Maciuk, A., Mangelsdorf, I., McNulty, B. A., et al. (2025) · EFSA Journal · doi:10.2903/j.efsa.2025.9537 · Cited by 2
Oken, H. A., Roizen, M. F., Ryan, A. S., & Playford, R. J. (2025) · Current Developments in Nutrition · doi:10.1016/j.cdnut.2025.107242 · Cited by 1
Probiotics In Incretin-Based Therapy for Patient Living with Obesity: A Synergistic Approach
Mattioli, M., D’Agostino, E., Valerii, L., Angelino, D., Serafini, M., & De Cristofaro, P. (2024) · Journal of Pharmacy and Pharmacology Research · doi:10.26502/fjppr.0102 · Cited by 1
Anissa, L., & Lestari, W. (2025) · World Nutrition Journal · doi:10.25220/wnj.v08.i2.0002 · Cited by 1
López-Daza, D. F., López-Ucrós, N., Posada-Álvarez, C., & Savino-Lloreda, P. (2024) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2024.04.004 · Cited by 1
Research works printed but not linked: 13
- Choi, 2019, Oral Collagen Supplementation: A Systematic Review of Dermatological Applications, J. Drugs Dermatol., 18, 9
- Modi, M., and Modi, K. (2025, November 19). Ginger Root, StatPearls, Available online: https://www.ncbi.nlm.nih.gov/books/NBK565886/.
- Guarneiri, 2025, Investigation of the Influence of a Bitter Melon Product on Indicators of Cardiometabolic Health in Adults with Prediabetes, J. Am. Nutr. Assoc., 44, 306
- Deguchi, 2000, Effectiveness of consecutive ingestion and excess intake of guava leaves tea in human volunteers, J. Jpn. Council. Adv. Food Ingred. Res., 3, 19
- Giacosa, 2015, Can nausea and vomiting be treated with ginger extract?, Eur. Rev. Med. Pharmacol. Sci., 19, 1291
- Pongrojpaw, 2007, A randomized comparison of ginger and dimenhydrinate in the treatment of nausea and vomiting in pregnancy, J. Med. Assoc. Thail., 90, 1703
- Dayib, 2020, Dietary fibers reduce obesity-related disorders: Mechanisms of action, Curr. Opin. Clin. Nutr. Metab. Care, 23, 445
- Barakat, 2020, Bovine Colostrum in the Treatment of Acute Diarrhea in Children: A Double-Blinded Randomized Controlled Trial, J. Trop. Pediatr., 66, 46
- Kannappan, 2006, Cinnamon bark extract improves glucose metabolism and lipid profile in the fructose-fed rat, Singap. Med. J., 47, 858
- Javed, 2012, Lipid lowering effect of Cinnamomum zeylanicum in hyperlipidaemic albino rabbits, Pak. J. Pharm. Sci., 25, 141
- Ahmad, 2025, Ameliorating implications of Psidium guajava L. (guava) leaf against metabolic syndromes—A review, J. Agric. Food Res., 21, 101867
- Amin, A.N., Intang, I.N., and Alfira, N. (2024). Effect of guajava (Psidium) leaves decoction on changes in blood glucose levels of people with diabetes mellitus. Proc. Optim., 1.
- Salaramoli, 2022, The effects of ginger and its constituents in the prevention of metabolic syndrome: A review, Iran. J. Basic Med. Sci., 25, 664
Cited by
Moscucci, F., Baratta, F., Pastori, D., Menichelli, D., Mattioli, A. V., Gallina, S., Lospinuso, I., Sciomer, S., Piccirillo, G., & Desideri, G. (2026) · Nutrients · doi:10.3390/nu18040632 · Cited by 11
“More-over, distributing protein intake evenly across meals has been found to be particularly effective, as it maximizes muscle protein synthesis throughout the day [72].”
Tjandrawinata, R. R., Rosari, B. P., Syahputra, R. A., Surya, R., & Nurkolis, F. (2026) · Nutrients · doi:10.3390/nu18030547 · Cited by 9
Dziewierz, A., & Siudak, Z. (2026) · Nutrients · doi:10.3390/nu18111761 · Cited by 3
“…to inhibit gastric emptying, reducing fat load per meal is a physiologically plausible and commonly recommended strategy to reduce postprandial nausea and fullness during GLP-1 RA titration, although randomized dietary-modification trials specifically in GLP-1-treated cohorts are lacking [66,67].”
Benito‐Vázquez, I., Rosell, M. D. L. Á., Lates-Profir, N., Díez‐Municio, M., Moreno, F. J., Frontela‐Saseta, C., & López-Nicolás, R. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107414 · Cited by 1
Beyond One-Size-Fits-All: Individually Tailored Dietary Interventions in Modern Obesity Care
Cozma-Petruț, A. P., Gherghel, M., Banc, R., Tișa, I. B., Stanciu, O., Coldea, T. E., Mudura, E., Miere, D., & Filip, L. A. (2026) · Nutrients · doi:10.3390/nu18162691 · Cited by 1
Metadata
- Authors
- Dias, D. D., Vasconcelos, A. R., Souza, A. C. R., Menezes, C. D., Silva, I. S. T. E., & Name, J. J.
- Affiliations
- Kilyos Assessoria, Cursos e Palestras, São Paulo 01311-100, Brazil
- Corresponding author
- Name, José João
- Venue
- Obesities
- Publisher
- MDPI AG
- Published
- 2025-12-02
- Volume
- 5
- Issue
- 4
- Pages
- 88
- ISSN
- 2673-4168 (ISSN-L)
- OpenAlex
- W4417124127
- Cited by
- 8
- References
- 324
- Citations by year
- 2026: 8
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Obesities (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- GLP-1 receptor agonists, obesity, omega-3 polyunsaturated fatty acids, lean mass loss, gastrointestinal adverse effects, weight regain, probiotics and prebiotics, flavonoids, anthocyanins, high-quality protein, gut microbiota, inflammation, body composition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.